Endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma

Annals of Surgical Oncology

Volumn 19, Issue 7, 2012, Pages 2149-2158

  Wang, Bing Yen ^a,b,e   Liu, Chao Yu ^b,e   Lin, Ching Hsiung ^c,d,e   Hsu, Po Kuei ^b,e   Hsu, Wen Hu ^b,e   Wu, Yu Chung ^b,e   Cheng, Ching Yuan ^a,e  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^e HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ENDOSCOPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84865124318     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2273-y     Document Type: Article

References (34)

1. Lightdale CJ. Esophageal cancer. Am J Gastroenterol. 1999;94: 20-9. (Pubitemid 29063440)
2. Thomas P, Doddoli C, Lienne P, et al. Changing patterns and surgical results in adenocarcinoma of the esophagus. Br J Surg. 1997;84:199-25.
3. Hofstetter W, Swisher SG, Correa AM, et al. Treatment outcomes of resected esophageal cancer. Ann Surg. 2002;236:376-85. (Pubitemid 34971347)
4. Ku GY, Ilson DH. Preoperative therapy for esophageal cancer. Gastroenterol Clin North Am. 2009;38:135-52.
5. Malaisrie SC, Untch B, Aranha GV, et al. Neoadjuvant chemo-radiotherapy for locally advanced esophageal cancer: experience at a single institution. Arch Surg. 2004;139:532-9. (Pubitemid 38585753)
6. Katrin MS, Bryan HB, Smithers BM, et al. Survival after neo-adjuvant chemotherapy or chemoradiotherapy for resectable esophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12:681-92.
7. Rice TW, Adelstein DJ. Precise clinical staging allows treatment modification of patients with esophageal carcinoma. Oncology (Huntingt). 1997;11:58-62. (Pubitemid 27425682)
8. Eloubeidi MA, Desmond R, Arguedas MR, et al. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer. 2002;95:1434-43.
9. Gaur P, Sepesi P, Hofstetter WL, et al. A clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients. Ann Surg. 2010;252:611-7.
10. Griffiths EA, Brummell Z, Gorthi G, et al. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses. J Surg Oncol. 2006;93:258-67. (Pubitemid 43329818)
11. Bolton WD, Hofstetter WL, Francis AM, et al. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2009;138:831-6.
12. Wang BY, Goan YG, Hsu PK, et al. Tumor length as a prognostic factor in esophageal squamous cell carcinoma. Ann Thorac Surg. 2011;91:887-93.
13. Yendamuri S, Swisher SG, Correa AM, et al. Esophageal tumor length is independently associated with long-term survival. Cancer. 2009;115:508-16.
14. Gaur P, Sepesi P, Hofstetter WL, et al. Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer. Cancer. 2011;117:63-9.
15. Edge SB, Byrd DR, Compton CC, et al. American Joint Committee on Cancer (AJCC) cancer staging manual. 7th ed. Chicago: Springer; 2010.
16. Van Vliet EP, Heijenbrok-Kal MH, Hunink MG, et al. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer. 2008;98:547-57. (Pubitemid 351214529)
17. Hsu WH, Hsu PK, Wang SJ, et al. Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma. Ann Thorac Surg. 2009;87: 1564-8.
18. Luketich JD, Schauer P, Landreneau R, et al. Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer. J Thorac Cardio-vasc Surg. 1997;114:817-23. (Pubitemid 27495871)
19. Salminen JT, Farkkila MA, Ramo OJ, et al. Endoscopic ultra-sonography in the preoperative staging of adenocarcinoma of the distal esophagus and esophagogastric junction. Scand J Gastro-enterol. 1999;34:1178-82. (Pubitemid 30026719)
20. Rosch T. Endoscopic ultrasonography: imaging and beyond. Gut. 2003;52:1220-6. (Pubitemid 36877441)
21. Schlick T, Heintz A, Junginger T. The examiner's learning effect and its influence on the quality of endoscopic ultrasonography in carcinoma of the esophagus and gastric cardia. Surg Endosc. 1999;13:894-8. (Pubitemid 29418861)
22. Fockens P, Van den Brande JH, van Dullemen HM, et al. En-dosonographic T-staging of esophageal carcinoma: a learning curve. Gastrointest Endosc. 1996;44:58-62. (Pubitemid 26268660)
23. Lizuka T, Isono K, Kakegawa T, et al. Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Japanese Committee for registration of esophageal carcinoma cases. Chest. 1989;96:1005-11. (Pubitemid 19266548)
24. Sobin LH, Hermanek P, Hutter RV. TNM classification of malignant tumors: a comparison between the new (1987) and the old editions. Cancer. 1988;61:2310-4.
25. Bhutani MS, Barde CJ, Markert RJ, et al. Length of esophageal cancer and degree of luminal stenosis during upper endoscopy predict T stage by endoscopic ultrasound. Endoscopy. 2002;34: 461-3. (Pubitemid 34601053)
26. Shinkai M, Niwa Y, Arisawa T, et al. Evaluation of prognosis of squamous cell carcinoma of the esophagus by endoscopic ultrasound. Gut. 2000;47:120-5. (Pubitemid 30430420)
27. Christopher P, Twine S, Ashley R, et al. Prognostic significance of endoluminal ultrasound-defined disease length and tumor volume (EDTV) for patients with the diagnosis of esophageal cancer. Surg Endosc. 2010;24:870-8.
28. Mariette C, Piessen G, Briez N, et al. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphade-nectomy extent. Ann Surg. 2008;247:365-71. (Pubitemid 351156783)
29. Altorki NK, Zhou XK, Stiles B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg. 2008;248:221-6.
30. Peyre CG, Hagen JA, DeMeester SR, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248:549-56.
31. Roder JD, Busch R, Stein HJ, et al. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg. 1994;81:410-3. (Pubitemid 24124822)
32. Goldstein NS, Soman A, Sacksner J et al. Disparate surgical margin lengths of colorectal resection specimens between in vivo and in vitro measurements. Am J Clin Pathol. 1999;111:349-51.
33. Siu KF, Cheung HC, Wong J. Shrinkage of the esophagus after resection for carcinoma. Ann Surg. 1986;203:173-6. (Pubitemid 16144705)
34. Bollschwerler E, Baldus SE, Schroder W, et al. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? J Surg Oncol. 2006;94:355-63. (Pubitemid 44465337)